Loading…

Protocol for sorting cancer stem cells using a combination of anti-CD133 antibody and lectin cyanovirin-N

CD133 is widely used as a marker to isolate cancer stem cells (CSCs). However, the structural ambiguity of N-glycan of CD133 limits its application in the isolation of CSCs. Here, we present a protocol to sort CSCs from tumor samples by combining CD133 with α-1,2-high-mannose type glycan chains. We...

Full description

Saved in:
Bibliographic Details
Published in:STAR protocols 2024-12, Vol.5 (4), p.103443, Article 103443
Main Authors: Wei, Yuanyan, Geng, Shuting, Chen, Qihang, Chen, Jiayue, Fan, Zhijun, Li, Yi, Si, Yu, Yang, Yuerong, Liang, Ziwei, Jiang, Jianhai
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:CD133 is widely used as a marker to isolate cancer stem cells (CSCs). However, the structural ambiguity of N-glycan of CD133 limits its application in the isolation of CSCs. Here, we present a protocol to sort CSCs from tumor samples by combining CD133 with α-1,2-high-mannose type glycan chains. We describe steps for purifying and biotinylating cyanovirin-N (CVN) proteins and sorting tumor cells and CD133+α-1,2-Man+ (α-1,2-linked mannose+) cells to provide more specific markers for CSCs. For complete details on the use and execution of this protocol, please refer to Wei et al.1 [Display omitted] •Detailed protocol for culturing primary cells of intrahepatic cholangiocarcinoma•Sorting cancer stem cells from intrahepatic cholangiocarcinoma tumor samples•α-1,2-Mannosylated CD133 is a marker for sorting and identifying cancer stem cells Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics. CD133 is widely used as a marker to isolate cancer stem cells (CSCs). However, the structural ambiguity of N-glycan of CD133 limits its application in the isolation of CSCs. Here, we present a protocol to sort CSCs from tumor samples by combining CD133 with α-1,2-high-mannose type glycan chains. We describe steps for purifying and biotinylating cyanovirin-N (CVN) proteins and sorting tumor cells and CD133+α-1,2-Man+ (α-1,2-linked mannose+) cells to provide more specific markers for CSCs.
ISSN:2666-1667
2666-1667
DOI:10.1016/j.xpro.2024.103443